132 related articles for article (PubMed ID: 11079017)
1. Hyperplasia of type II pneumocytes in pulmonary lymphangioleiomyomatosis.
Matsui K; K Riemenschneider W; Hilbert SL; Yu ZX; Takeda K; Travis WD; Moss J; Ferrans VJ
Arch Pathol Lab Med; 2000 Nov; 124(11):1642-8. PubMed ID: 11079017
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis.
Evans SE; Colby TV; Ryu JH; Limper AH
Chest; 2004 Mar; 125(3):1063-70. PubMed ID: 15006970
[TBL] [Abstract][Full Text] [Related]
3. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.
Maruyama H; Seyama K; Sobajima J; Kitamura K; Sobajima T; Fukuda T; Hamada K; Tsutsumi M; Hino O; Konishi Y
Mod Pathol; 2001 Jun; 14(6):609-14. PubMed ID: 11406664
[TBL] [Abstract][Full Text] [Related]
4. Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis.
Merrilees MJ; Hankin EJ; Black JL; Beaumont B
J Pathol; 2004 Jun; 203(2):653-60. PubMed ID: 15141380
[TBL] [Abstract][Full Text] [Related]
5. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis.
Matsumoto Y; Horiba K; Usuki J; Chu SC; Ferrans VJ; Moss J
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):327-36. PubMed ID: 10460750
[TBL] [Abstract][Full Text] [Related]
6. Sheep pox virus induces proliferation of type II pneumocytes in the lungs.
Beytut E
J Comp Pathol; 2010; 143(2-3):132-41. PubMed ID: 20181359
[TBL] [Abstract][Full Text] [Related]
7. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
Ferrans VJ; Yu ZX; Nelson WK; Valencia JC; Tatsuguchi A; Avila NA; Riemenschn W; Matsui K; Travis WD; Moss J
J Nippon Med Sch; 2000 Oct; 67(5):311-29. PubMed ID: 11031360
[TBL] [Abstract][Full Text] [Related]
8. [A case of micronodular pneumocyte hyperplasia, lymphangiomyomatosis associated with tuberous sclerosis].
Kawashima M; Kobayashi H; Tominaga M; Yathunami J; Hayashi S
Nihon Kokyuki Gakkai Zasshi; 2001 Apr; 39(4):277-80. PubMed ID: 11481828
[TBL] [Abstract][Full Text] [Related]
9. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.
Matsui K; Takeda K; Yu ZX; Travis WD; Moss J; Ferrans VJ
Arch Pathol Lab Med; 2000 Feb; 124(2):267-75. PubMed ID: 10656737
[TBL] [Abstract][Full Text] [Related]
10. Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis.
Lantuejoul S; Ferretti G; Negoescu A; Parent B; Brambilla E
Histopathology; 1997 Jun; 30(6):570-5. PubMed ID: 9205862
[TBL] [Abstract][Full Text] [Related]
11. Micronodular pneumocyte hyperplasia.
Muir TE; Leslie KO; Popper H; Kitaichi M; Gagné E; Emelin JK; Vinters HV; Colby TV
Am J Surg Pathol; 1998 Apr; 22(4):465-72. PubMed ID: 9537475
[TBL] [Abstract][Full Text] [Related]
12. Multifocal micronodular pneumocyte hyperplasia: a distinctive pulmonary manifestation of tuberous sclerosis.
Guinee D; Singh R; Azumi N; Singh G; Przygodzki RM; Travis W; Koss M
Mod Pathol; 1995 Dec; 8(9):902-6. PubMed ID: 8751329
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury.
Bardales RH; Xie SS; Schaefer RF; Hsu SM
Am J Pathol; 1996 Sep; 149(3):845-52. PubMed ID: 8780388
[TBL] [Abstract][Full Text] [Related]
14. Distribution and mRNA expression of insulin-like growth factor system in pulmonary lymphangioleiomyomatosis.
Valencia JC; Matsui K; Bondy C; Zhou J; Rasmussen A; Cullen K; Yu ZX; Moss J; Ferrans VJ
J Investig Med; 2001 Sep; 49(5):421-33. PubMed ID: 11523698
[TBL] [Abstract][Full Text] [Related]
15. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K
Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436
[TBL] [Abstract][Full Text] [Related]
16. Plutonium-induced proliferative lesions and pulmonary epithelial neoplasms in the rat: immunohistochemical and ultrastructural evidence for their origin from type II pneumocytes.
Herbert RA; Stegelmeier BS; Gillett NA; Rebar AH; Carlton WW; Singh G; Hahn FF
Vet Pathol; 1994 May; 31(3):366-74. PubMed ID: 8053132
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study.
Matsui K; Takeda K; Yu ZX; Valencia J; Travis WD; Moss J; Ferrans VJ
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):1002-9. PubMed ID: 10712355
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary lymphangioleiomyomatosis. Morphologic and immunohistochemical findings].
Kuhnen C; Preisler K; Müller KM
Pathologe; 2001 May; 22(3):197-204. PubMed ID: 11402850
[TBL] [Abstract][Full Text] [Related]
19. Multifocal micronodular pneumocyte hyperplasia in a postmenopausal woman with tuberous sclerosis.
Yamanaka A; Kitaichi M; Fujimoto T; Hirai T; Hori H; Konishi F
Virchows Arch; 2000 Apr; 436(4):389-92. PubMed ID: 10834544
[TBL] [Abstract][Full Text] [Related]
20. Lung adenocarcinoma with type II pneumocyte characteristics.
Tsutahara S; Shijubo N; Hirasawa M; Honda Y; Satoh M; Kuroki Y; Akino T
Eur Respir J; 1993 Jan; 6(1):135-7. PubMed ID: 8425584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
